TCL Archive Merck Serono Cancels Tecemotide Program In NSCLC, Including Two Phase III Trials September 26, 2014
TCL Archive Benno Schmidt, 86, Cancer Act Advocate, Chairman Of MSKCC boards, Cancer Panel October 29, 1999